Cited by 423Dementia and Cognitive Impairment ResearchIntracerebral and Subarachnoid Hemorrhage ResearchAlzheimer's disease research and treatments

Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons

Open access
Boyle, Patricia A., Yu, Lei, Nag, Sukriti, Leurgans, Sue, Wilson, Robert S., Bennett, David A., Schneider, Julie A.·2015·Neurology

Abstract

OBJECTIVE: We tested the hypothesis that cerebral amyloid angiopathy (CAA) is related to Alzheimer disease (AD) dementia and decline in multiple cognitive systems in old age, independent of AD plaque and tangle pathology and other common age-related neuropathologies. METHODS: Participants (n = 1,113) came from 2 longitudinal clinical-pathologic studies of aging, the Rush Memory and Aging Project and the Religious Orders Study. All underwent annual clinical evaluations including detailed cognitive testing for a mean of 7.1 years before death. Clinical diagnoses of AD were established after reviewing all clinical data, blinded to neuropathologic information. Neuropathologic examinations provided measures of CAA, AD pathology, macroscopic infarcts, microinfarcts, and neocortical Lewy bodies. The association of CAA with AD dementia was examined using logistic regression models, and its association with cognitive decline was examined using linear mixed models. RESULTS: CAA was common, present in 78.9% of participants, and moderately related to AD pathology (ρ = 0.401, p < 0.0001). In analyses adjusted for plaques, tangles, and other common age-related neuropathologies, CAA was associated with an increased odds of AD dementia (odds ratio = 1.237, 95% confidence interval 1.082-1.414) and an increased rate of decline in global cognition, perceptual speed, episodic memory, and semantic memory. The associations of CAA with cognitive outcomes were not driven by the presence of capillary involvement. CONCLUSIONS: CAA is an important determinant of AD dementia and decline in multiple cognitive systems in old age.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000002175

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human AD studies found that both E4 and E2 carriage were associated with higher CAA compared to E3/E3 individuals.

    “These findings may reflect human AD studies in which both E4 and E2 carriage were associated with higher CAA compared to E3/E3 individuals47,48”

    From APOE4 to APOE2 allelic switching in mice improves Alzheimer’s disease-related metabolic signatures, neuropathology and cognition (2025) · cites this paper as [47]

    The Burden of CAA section reports an association between CAA and AD pathology, but does not compare CAA burden by APOE genotype. Searches for APOE, apolipoprotein E, and the E2/E4 alleles found no passage addressing whether either allele is associated with higher CAA than E3/E3. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Advanced stage CAA in AD patients aggravates cognitive decline and enhances odds of triggering dementia onset.

    “Advanced stage CAA in AD patients aggravates cognitive decline and enhances odds of triggering dementia onset [603].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Save These Dates for AAN CME Opportunities! Mark these dates on your calendar for exciting continuing education conferences by the American Academy of Neurology. Learn more at AAN.com/conferences. 2016 Breakthroughs in Neurology Conference • January 15-18, 2016, Orlando, FL, Omni Orlando Resort at ChampionsGate AAN Annual Meeting • April 15-21, 2016, Vancouver, BC, Canada, Vancouver Convention Centre

Cited by

Sorted by citations

Authors
Boyle, P. A., Yu, L., Nag, S., Leurgans, S., Wilson, R. S., Bennett, D. A., & Schneider, J. A.
Affiliations
Rush University Medical Center (US)
Venue
Neurology
Published
2015-12
Volume
85
Issue
22
Pages
1930-1936
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2166148093
Cited by
423
References
28
Citations by year
2026: 45 · 2025: 55 · 2024: 60 · 2023: 38 · 2022: 46 · 2021: 43 · 2020: 31 · 2019: 31 · 2018: 24 · 2017: 28 · 2016: 20 · 2014: 1
FWCI
19.37
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (R01AG017917, R01AG042210, R01AG015819, P30AG010161, RF1AG015819, R01AG034374)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
cerebral amyloid angiopathy, cognitive decline, older adults, Alzheimer disease pathology, amyloid plaques, neurofibrillary tangles, microinfarcts, Lewy bodies, perceptual speed, episodic memory, semantic memory, global cognition, neuropathology
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Cognition, Cognition Disorders, Female, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Cerebral Amyloid Angiopathy, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review